VIAP (VIAP) Stock Price & Analysis
VIAP (VIAP) rose 0.00% to USD 0 as of June 10, 2026 at 04:03 UTC, according to Nexqual real-time market data.
VIAP last closed at USD 0; the session ranged USD 0–0 on volume of 700 shares. Market capitalization is $10,279, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 04:03 UTC.
Key Statistics (as of June 10, 2026 at 04:03 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 700 shares |
| Market Cap | $10,279 |
| Exchange | PNK |
Technical Analysis (VIAP)
Nexqual's technical model rates VIAP "BUY" based on 4 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 04:03 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (VIAP)
Wall Street analysts rate VIAP "None", per Nexqual as of June 10, 2026 at 04:03 UTC.
| Consensus Rating | None |
|---|
Earnings (VIAP)
Source: Nexqual, June 10, 2026 at 04:03 UTC.
Financials & Fundamentals (VIAP)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.02 |
| Total Cash | $84,001 |
| Total Debt | $14.00M |
| Free Cash Flow | $-3.62M |
Source: Nexqual, June 10, 2026 at 04:03 UTC.
Financial Health Score (VIAP)
Nexqual rates VIAP's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 04:03 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $84K cash vs $14M debt |
| Cash Flow | Weak — Operating cash flow -$6M |
| Efficiency | Mixed — No data |
Ownership (VIAP)
| Shares Outstanding | 20.56M |
|---|
Source: Nexqual, June 10, 2026 at 04:03 UTC.
Leadership (VIAP)
VIAP is led by Thomas Quertermous FACC (age 73), Chief Scientific Officer & Member of Scientific Advisory Board, per Nexqual as of June 10, 2026 at 04:03 UTC.
| Chief Scientific Officer & Member of Scientific Advisory Board | Thomas Quertermous FACC (age 73) |
|---|
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PARD | PONIARD PHARMACEUT | USD 0 | ▲ 0% |
| NTII | NEUROBIOLOGICAL TECHNOLOGIES IN | USD 0 | ▲ 0% |
| ARYX | ARYX THERAPEUTICS INC | USD 0 | ▲ 0% |
| CAPS | Capstone Holding Corp. | USD 0.31 | ▼ 2.5% |
| PANC | PANACOS PHARMACEUTICALS INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:03 UTC. This page is informational and not investment advice.